Cargando…
Effect of gender‐affirming hormone use on coagulation profiles in transmen and transwomen
BACKGROUND: The transgender population that uses gender‐affirming hormone therapy (GAHT) is rapidly growing. The (side) effects of GAHT are largely unknown. We examined the effect of GAHT on coagulation parameters associated with venous thromboembolism (VTE) risk. METHODS: Factor (F)II, FIX, FXI, pr...
Autores principales: | Scheres, Luuk J.J., Selier, Nienke L.D., Nota, Nienke M., van Diemen, Jeske J.K., Cannegieter, Suzanne C., den Heijer, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048491/ https://www.ncbi.nlm.nih.gov/pubmed/33527671 http://dx.doi.org/10.1111/jth.15256 |
Ejemplares similares
-
Gender‐Affirming Hormone Treatment Decreases Bone Turnover in Transwomen and Older Transmen
por: Vlot, Mariska C, et al.
Publicado: (2019) -
Bone Safety During the First Ten Years of Gender‐Affirming Hormonal Treatment in Transwomen and Transmen
por: Wiepjes, Chantal M, et al.
Publicado: (2018) -
Measurement of coagulation factors during rivaroxaban and apixaban treatment: Results from two crossover trials
por: Scheres, Luuk J. J., et al.
Publicado: (2018) -
Switching from vitamin K antagonists to direct oral anticoagulants: Treatment satisfaction and patient concerns
por: Toorop, Myrthe M. A., et al.
Publicado: (2020) -
Brain connectivity dynamics in cisgender and transmen people with gender incongruence before gender affirmative hormone treatment
por: Uribe, Carme, et al.
Publicado: (2021)